# Aulos

**Canonical:** https://apis.io/providers/aulos/  
**Website:** https://aulosbio.com/  
**APIs profiled:** 0

Aulos Bioscience develops an immune‑activating antibody therapeutic, imneskibart (AU‑007), that binds the interleukin‑2 region interacting with the CD25 receptor to shift IL‑2 activity toward immune activation and away from suppression. The company is advancing this investigational product in Phase 1/2 trials for patients with unresectable locally advanced or metastatic solid‑tumor cancers, including melanoma and renal cell carcinoma. Its focus is on delivering a novel IL‑2‑based therapy to cancer patients and the clinical research community.

## Kin Score — 11.1 / 100 (emerging)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 11.1).

| Facet | Score |
|---|---|
| Discoverability | 51.8 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 9.5 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 10.9 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Aulos Domain Security** — TLSv1.3 · HSTS

## Tags

Oncology, Biopharma, Antibody Therapeutics, IL-2 Therapeutics, Clinical Trials

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/aulos/). Scores are computed from the provider's own public artifacts under a published rubric.